Livedoid vasculopathy: Current meaning. A report of two cases;Vasculopatía livedoide: Significado actual. Comunicación de dos casos

Dermatologia Revista Mexicana

Volumn 52, Issue 4, 2008, Pages 175-181

  Poletti, Edgar David ^a,e   Munoz Sandoval N R ^b   Moreno Gonzalez J L ^c,d   Santacruz Torres, A ^e  

^a UNIVERSIDAD AUTÓNOMA DE AGUASCALIENTES   (Mexico)

^b Clínica en Derma Norte de Aguascalientes

^c HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^d Residencial Bosques del Prado ^*

^e Residencial Bosques del Prado   (Mexico)

Author keywords

Atrophie blanche; Endothelial damage; Leg ulcer; Livedoid vasculopathy; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; ENOXAPARIN; FLUINDIONE; HEPARIN; ILOPROST; IMMUNOGLOBULIN; INDOBUFEN; METHOXSALEN; NICOTINIC ACID; NIFEDIPINE; PENTOXIFYLLINE; PROSTAGLANDIN; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CHRONIC PAIN; CLINICAL EVALUATION; CLINICAL FEATURE; COMORBIDITY; DRUG EFFICACY; DRUG PULSE THERAPY; ENDOTHELIUM INJURY; FEMALE; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; LEG ULCER; LIVEDOID VASCULOPATHY; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PHOTOCHEMOTHERAPY; PUVA; SKIN DISEASE; SYSTEMIC DISEASE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; TREATMENT RESPONSE;

EID: 50649102537     PISSN: 01854038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jenette JC, Falk R, Andrassy K, Bacon Pa, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
2. st ed. New York: Oxford University Press, 2001;pp:11-16.
3. Jorizzo JL. Livedoid vasculopathy: what is it? Arch Dermatol 1998;134(4):491-3.
4. Shornick JK, Nicholes BK, Bergstresser PR, Gilliam JN. Idiopathic atrophie blanche. J Am Acad Dermatol 1983;8:792-8.
5. Maessen-Visch MB, Koedam MI, Hamulayak K, Neumann HA. Atrophie banche. Int J Dermatol 199;38:161-72.
6. Suárez SM, Paller AS. Atrophie blanche with onset in childhood. J Pediatr 1993;123:753-5.
7. Guerrero-Gutierrez E, Soto-Ortiz JA. Úlcera dolorosa sobre placas atŕficas en las piernas. Casos para diagństico. Revista Piel 2000;2:234-5.
8. Elisaf M, Nikou-Stefansky S, Drosos AA, Moutsopoulos HM. Atrophie blanche. Clinical diagnosis and treatment. Ann Med Interne (Paris) 1991;142:415-8.
9. Sumpio BE. Foot ulcers. N Engl J Med 2000;343:787-93.
10. nd ed. Philadelphia: Mosby Elsevier, 2006;pp:178-9.
11. Miller OF, Phillips TJ. Leg ulcers. J Am Acad Dermatol 2000;43(1 Part 1):91-95.
12. th ed. New York: McGraw Hill, 2008;pp:1606-16.
13. nd ed. London: Mosby-Elsevier, 2008;pp:347-67.
14. rd ed. Philadelphia: Saunders, 2003;pp:25-29.
15. Bryant C. Atrophie blanche: a review from the perspective of a 31 patient cohort. Dermatol Ther 2001;14:111-6.
16. Grattan CE, Burton JL, Boon AP. Sneddon's syndrome (livedo reticularis and cerebral thrombosis) with livedo vasculitis and anticardiolipin antibodies. Br J Dermatol 1999;140:131-5.
17. Maessen-Visch MB, Hamulyak K, Tazelaar DJ, Crombag NH, Neumann HA. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol 1999;135:41-44.
18. Browning CE, Callen JP. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol 2006;142:75-78.
19. Davis MDP, Wysokinski WE. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: response to warfarin. J Am Acad Dermatol 2008;58:512-5.
20. McCalmont CS, McCalmont TH, Jorizzo JL, White WL, et al. Livedo vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol 1992;17:4-8.
21. Papi M, Didona BD, Pita O. Livedo vasculopathy vs small vessel cutaneous vasculitis. Cytokine ans platelet P-selectin studies. Arch Dermatol 1998;134:447-52.
22. Cardoso R, Gonçalo M, Tellechea O, Maia R, et al. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome. Int J Dermatol 2007;46:431-4.
23. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 1999;140:131-5.
24. Otoyama K, Katayama I, Kondo S, Nishioka K, Nishiyama S. A case of Sneddon's syndrome with positive ANA and anticardiolipin antibodies: primary anti-phospholipid syndrome? J Dermatol 1990;17:489-92.
25. Schroeter AL, Diaz-Perez JL, Winkelmann RK, Jordan RE. Livedo vasculitis (the vasculitis of atrophie blanche): immunohistopathologic study. Arch Dermatol 1975;111:188-93.
26. Kern AB. Atrophie blanche: report of two patients treated with aspirin and dipyridamole. J Am Acad Dermatol 1982;6:1048-53.
27. Drucker CR, Duncan WC. Antiplatelet therapy in atrophie blanche and livedo vasculitis. J Am Acad Dermatol 1982;7:359-63.
28. Sauer GC. Pentoxifylinne (Trental) therapy for the vasculitis of atrophie blanche. Arch Dermatol 1986;122:380-1.
29. Hairston BR, Davis MD, Gibson LE, Drage LA. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol 2003;139:987-90.
30. Lee JH, Choi HJ, Kim SM. Livedoid vasculitis responding to PUVA therapy. Int J Dermatol 2001;40:153-7.
31. Kreuter A, Gambichler T, Breuckmann F, Bechara FG, et al. Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients. J Am Acad Dermatol 2004;51:574-9.
32. Jolles S, Hughes J, Whittaker S. Dermatogical uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998;134:80-86.
33. Amita H, Levy Y , Shoenfeld Y. Use of intravenous immunoglobulin in livedo vasculitis. Clin Exp Rheumatology 2000;18:404-6.
34. Dahl MV, Bridges AG. Intravenous immune globulin: fighting antibodies with antibodies. J Am Acad Dermatol 2001;45:775-83.